PUBLICACIÓN

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

ACCEDER A LA PUBLICACIÓN: Scopus

Gomez Garcia L.M. et al.

2021 Clinical Lymphoma, Myeloma and Leukemia

Cancer Research (Q3), Hematology (Q2), Oncology (Q2)

JCR: 2.822

SJR: 0.778


CITAS

10

DOI

10.1016/j.clml.2021.01.013

EID

2-s2.0-85101128565

ISSN

2152-2650

EISSN

2152-2669


AUTORES DE LA UEX